[Seite 40↓]


1. Chiari H. Über Selbstverdauung des menschlichen Pankreas. Z.Heilkd. 1896; 17: 69-96.

2. Whitcomb DC, Gorry MC, Preston RA et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat.Genet. 1996; 14: 141-5.

3. DiMagno, E. P., Reber, H. A., and Tempero, M. A. AGA Technical Review on the Epidemiology, Diagnosis and Treatment of Pancreatic Ductal Adenocarcinoma. Gastroenterology 117(6), 1464-1484. 1999.

4. Gullo L, Migliori M, Olah A et al. Acute pancreatitis in five European countries: etiology and mortality. Pancreas 2002; 24: 223-7.

5. Lankisch P, Assmus C, Maisonneuve P, Lowenfels A. Die Epidemiologie von Pankreaserkrankungen in Deutschland. Z.Gastroenterol. 2002; 39: 653.

6. Lankisch PG, Burchard-Reckert S, Petersen M et al. Morbidity and mortality in 602 patients with acute pancreatitis seen between the years 1980-1994. Z.Gastroenterol. 1996; 34: 371-7.

7. Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 2001; 120: 682-707.

8. DiMagno EP. Gene mutations and idiopathic chronic pancreatitis: clinical implications and testing. Gastroenterology 2001; 121: 1508-12.

9. Durbec JP, Sarles H. Multicenter survey of the etiology of pancreatic diseases. Relationship between the relative risk of developing chronic pancreaitis and alcohol, protein and lipid consumption. Digestion 1978; 18: 337-50.

10. Gumaste VV. Alcoholic pancreatitis: unraveling the mystery. Gastroenterology 1995; 108: 297-9.

11. Ockenga J, Vogel A, Teich N, Keim V, Manns MP, Strassburg CP. UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer. Gastroenterology. 2003 Jun; 124(7): 1802-8.

12. Bourliere M, Barthet M, Berthezene P, Durbec JP, Sarles H. Is tobacco a risk factor for chronic pancreatitis and alcoholic cirrhosis? Gut 1991; 32: 1392-5.

13. Lin Y, Tamakoshi A, Hayakawa T, Ogawa M, Ohno Y. Cigarette smoking as a risk factor for chronic pancreatitis: a case- control study in Japan. Research Committee on Intractable Pancreatic Diseases. Pancreas 2000; 21: 109-14.

[Seite 41↓]

14. Talamini G, Bassi C, Falconi M et al. Alcohol and smoking as risk factors in chronic pancreatitis and pancreatic cancer. Dig.Dis.Sci. 1999; 44: 1303-11.

15. Wallig MA, Gould DH, Fettman MJ. Selective pancreato-toxicity in the rat induced by the naturally occurring plant nitrile 1-cyano-2-hydroxy-3-butene. Food Chem.Toxicol. 1988; 26: 137-47.

16. Wallig MA. Xenobiotic metabolism, oxidant stress and chronic pancreatitis. Focus on glutathione. Digestion 1998; 59 Suppl 4: 13-24.

17. Whitcomb DC, Gorry MC, Preston RA et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat.Genet. 1996; 14: 141-5.

18. Rinderknecht H. Activation of pancreatic zymogens. Normal activation, premature intrapancreatic activation, protective mechanisms against inappropriate activation. Dig.Dis.Sci. 1986; 31: 314-21.

19. Halangk W, Lerch MM, Brandt-Nedelev B et al. Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J.Clin.Invest 2000; 106: 773-81.

20. Halangk W, Kruger B, Ruthenburger M et al. Trypsin activity is not involved in premature, intrapancreatic trypsinogen activation. Am.J.Physiol Gastrointest.Liver Physiol 2002; 282: G367-G374.

21. Lerch MM, Halangk W, Kruger B. The role of cysteine proteases in intracellular pancreatic serine protease activation. Adv.Exp.Med.Biol. 2000; 477: 403-11.: 403-11.

22. Teich N, Bodeker H, Keim V. Cathepsin B cleavage of the trypsinogen activation peptide. BMC.Gastroenterol. 2002; 2: 16.

23. Kukor Z, Mayerle J, Kruger B et al. Presence of cathepsin B in the human pancreatic secretory pathway and its role in trypsinogen activation during hereditary pancreatitis. J.Biol.Chem. 2002; 277: 21389-96.

24. Lerch MM, Gorelick FS. Early trypsinogen activation in acute pancreatitis. Med.Clin.North Am. 2000; 84: 549-63, viii.

25. Rau B, Poch B, Gansauge F et al. Pathophysiologic role of oxygen free radicals in acute pancreatitis: initiating event or mediator of tissue damage? Ann.Surg. 2000; 231: 352-60.

26. Schoenberg MH, Birk D, Beger HG. Oxidative stress in acute and chronic pancreatitis. Am.J.Clin.Nutr. 1995; 62: 1306S-14S.

27. Aw, TY. Molecular und cellular response to oxidative stress and changes in oxidation-reduction imbalance in the intestine. Am.J.Clin.Nutr. 70, 557-565. 1999.

[Seite 42↓]

28. Chen X, Ji B, Han B, Ernst SA, Simeone D, Logsdon CD. NF-kappaB activation in pancreas induces pancreatic and systemic inflammatory response. Gastroenterology 2002; 122: 448-57.

29. Matilla B, Ortiz J, Gonzalez P et al. Effects of parenteral nutrition supplemented with glutamine or glutamine dipeptides on liver antioxidant and detoxication systems in rats. Nutrition 2000; 16: 125-8.

30. Wernerman J, Hammarqvist F. Modulation of endogenous glutathione availability. Curr.Opin.Clin.Nutr.Metab Care 1999; 2: 487-92.

31. Ockenga J, Borchert K, Rifai K, Manns M, BISCHOFF S. Effect of glutamine-enriched total parenteral nutrition in patients with acute pancreatitis. Clin.Nutr. 2002; 21: 409.

32. Jalleh RP, Gilbertson JA, Williamson RC, Slater SD, Foster CS. Expression of major histocompatibility antigens in human chronic pancreatitis. Gut 1993; 34: 1452-7.

33. Slater S, Jalleh R, Gilbertson J, Lampert I, Williamson R, Foster CS. Expression of heat shock proteins in chronic pancreatitis: protective or pathogenic roles? Lab Invest 1997; 76: 533-45.

34. Layer P, DiMagno EP. Early and late onset in idiopathic and alcoholic chronic pancreatitis. Different clinical courses. Surg.Clin.North Am. 1999; 79: 847-60.

35. Ammann RW. The natural history of alcoholic chronic pancreatitis. Intern.Med. 2001; 40: 368-75.

36. Ammann RW, Heitz PU, Kloppel G. Course of alcoholic chronic pancreatitis: a prospective clinicomorphological long-term study. Gastroenterology 1996; 111: 224-31.

37. Hunger RE, Mueller C, Z'graggen K, Friess H, Buchler MW. Cytotoxic cells are activated in cellular infiltrates of alcoholic chronic pancreatitis. Gastroenterology 1997; 112: 1656-63.

38. Friess H, Buchler MW, Mueller C, Malfertheiner P. Immunopathogenesis of chronic pancreatitis. Gastroenterology 1998; 115: 1018-22.

39. Ebert MP, Ademmer K, Muller-Ostermeyer F et al. CD8+CD103+ T cells analogous to intestinal intraepithelial lymphocytes infiltrate the pancreas in chronic pancreatitis. Am.J.Gastroenterol. 1998; 93: 2141-7.

40. Kontiainen S, Scheinin T, Halme L. Number of activated T-helper cells and NK cells in peripheral blood is decreased in severe Crohn's disease. APMIS 1996; 104: 355-61.

41. Yamada T, Hashimoto T, Sogawa M et al. Role of T cells in development of chronic pancreatitis in male Wistar Bonn/Kobori rats: effects of tacrolimus. Am.J.Physiol Gastrointest.Liver Physiol 2001; 281: G1397-G1404.

[Seite 43↓]

42. Ockenga J, Jacobs R, Kemper A, Benschop RJ, Schmidt RE, Manns MP. Lymphocyte subsets and cellular immunity in patients with chronic pancreatitis. Digestion 2000; 62: 14-21.

43. Ockenga J, Grabowski J, Martin M, Bischoff SC, Gebel M, Manns MP. Transforming Growth Factor-beta and soluble Tumor-Necrosis-Factor-P75 in chronic Pancreatitis. Gastroenterology 1997; 112: A469.

44. Sarles H, Sarles JC, Camatte R et al. Observations on 205 confirmed cases of acute pancreatitis, recurring pancreatitis, and chronic pancreatitis. Gut 1965; 6: 545-59.

45. Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut 2002; 51: 1-4.

46. Haber PS, Keogh GW, Apte MV et al. Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am.J.Pathol. 1999; 155: 1087-95.

47. Bachem MG, Schmidt-Kostsas A, Gross.H.J. et al. Pancreatic stellate cells and their role in human pancreatic fibrogenesis. In: Büchler MW, Friess H, Uhl W, Malfertheiner P, eds. Chronic Pancreatitis. Berlin: Blackwell 2002: 134-47.

48. Apte MV, Phillips PA, Fahmy RG et al. Does alcohol directly stimulate pancreatic fibrogenesis? Studies with rat pancreatic stellate cells. Gastroenterology 2000; 118: 780-94.

49. Comfort, M. W. and Steinberg, A. G. Pedegree of a family with hereditary pancreatitis. Gastroenterology 21, 54-63. 1952.

50. Whitcomb DC, Preston RA, Aston CE et al. A gene for hereditary pancreatitis maps to chromosome 7q35. Gastroenterology 1996; 110: 1975-80.

51. Keim V, Bauer N, Teich N, Simon P, Lerch MM, Mossner J. Clinical characterization of patients with hereditary pancreatitis and mutations in the cationic trypsinogen gene. Am.J.Med. 2001; 111: 622-6.

52. Teich N, Ockenga J, Keim V, Mossner J. Genetic risk factors in chronic pancreatitis. J.Gastroenterol. 2002; 37: 1-9.

53. Teich N, Ockenga J, Hoffmeister A, Manns M, Mossner J, Keim V. Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation. Gastroenterology 2000; 119: 461-5.

54. Witt H, Luck W, Becker M. A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis. Gastroenterology 1999; 117: 7-10.

55. Ferec C, Raguenes O, Salomon R et al. Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis. J.Med.Genet. 1999; 36: 228-32.

[Seite 44↓]

56. Kukor Z, Mayerle J, Kruger B et al. Presence of cathepsin B in the human pancreatic secretory pathway and its role in trypsinogen activation during hereditary pancreatitis. J.Biol.Chem. 2002; 277: 21389-96.

57. Sahin-Toth M. Human cationic trypsinogen. Role of Asn-21 in zymogen activation and implications in hereditary pancreatitis. J.Biol Chem. 2000; 275: 22750-5.

58. Sahin-Toth M. The pathobiochemistry of hereditary pancreatitis: studies on recombinant human cationic trypsinogen. Pancreatology. 2001; 1: 461-5.

59. Simon P, Weiss FU, Sahin-Toth M et al. Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122 --> Cys) that alters autoactivation and autodegradation of cationic trypsinogen. J.Biol.Chem. 2002; 277: 5404-10.

60. Teich N, Bauer N, Mossner J, Keim V. Mutational screening of patients with nonalcoholic chronic pancreatitis: identification of further trypsinogen variants. Am.J.Gastroenterol. 2002; 97: 341-6.

61. Keim V, Hoffmeister A, Teich N et al. The pancreatitis-associated protein in hereditary and chronic alcoholic pancreatitis. Pancreas 1999; 19: 248-54.

62. Chen JM, Audrezet MP, Mercier B, Quere I, Ferec C. Exclusion of anionic trypsinogen and mesotrypsinogen involvement in hereditary pancreatitis without cationic trypsinogen gene mutations. Scand.J.Gastroenterol. 1999; 34: 831-2.

63. Matozaki T, Sakamoto C, Suzuki T et al. Idiopathic chronic calcifying pancreatitis with diabetes mellitus. Analysis of pancreatic stone protein gene. Dig.Dis.Sci. 1993; 38: 963-7.

64. Witt H, Luck W, Hennies HC et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat.Genet. 2000; 25: 213-6.

65. Pfutzer RH, Barmada MM, Brunskill AP et al. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000; 119: 615-23.

66. Ockenga J, Dork T, Stuhrmann M. Low prevalence of SPINK1 gene mutations in adult patients with chronic idiopathic pancreatitis. J.Med.Genet. 2001; 38: 243-4.

67. Witt H, Luck W, Becker M et al. Mutation in the SPINK1 trypsin inhibitor gene, alcohol use, and chronic pancreatitis. JAMA 2001; 285: 2716-7.

68. Noone PG, Zhou Z, Silverman LM, Jowell PS, Knowles MR, Cohn JA. Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology 2001; 121: 1310-9.

[Seite 45↓]

69. Chandak GR, Idris MM, Reddy DN, Bhaskar S, Sriram PV, Singh L. Mutations in the pancreatic secretory trypsin inhibitor gene (PSTI/SPINK1) rather than the cationic trypsinogen gene (PRSS1) are significantly associated with tropical calcific pancreatitis. J.Med.Genet. 2002; 39: 347-51.

70. Bhatia, E., Choudhuri, G., Sikora, S. S., Lundt, O., Kage, A., Becker, M., and Witt, H. Tropical calcific Pancreatitis: Strong Association with SPINK1 Trypsin Inhibitor Mutations. Gastroenterology 123. 2002.

71. Whitcomb DC. Pancreatic bicarbonate secretion: role of CFTR and the sodium-bicarbonate cotransporter. Gastroenterology 1999; 117: 275-7.

72. Freedman SD, Katz MH, Parker EM, Laposata M, Urman MY, Alvarez JG. A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice. Proc.Natl.Acad.Sci.U.S.A 1999; 96: 13995-4000.

73. Freedman SD, Blanco P, Shea JC, Alvarez JG. Mechanisms to explain pancreatic dysfunction in cystic fibrosis. Med.Clin.North Am. 2000; 84: 657-64, x.

74. Freedman SD, Kern HF, Scheele GA. Pancreatic acinar cell dysfunction in CFTR(-/-) mice is associated with impairments in luminal pH and endocytosis. Gastroenterology 2001; 121: 950-7.

75. Zielenski, J. and Tsui, L. C. Cystic Fibrosis: Genotyping and Phenotyping Variations. Annu.Rev.Genetics. 29, 777-807. 2002.

76. Cohn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM, Jowell PS. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N.Engl.J.Med. 1998; 339: 653-8.

77. Sharer N, Schwarz M, Malone G et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N.Engl.J.Med. 1998; 339: 645-52.

78. Ockenga J, Stuhrmann M, Ballmann M et al. Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis. Am.J.Gastroenterol. 2000; 95: 2061-7.

79. Ockenga J, Stuhrmann M, Manns MP. Evaluation of the role of CFTR in alcohol related pancreatic disease. Gut 2001; 49: 312-3.

80. Gomez LM, Patuzzo C, Castellani C et al. CFTR and cationic trypsinogen mutations in idiopathic pancreatitis and neonatal hypertrypsinemia. Pancreatology. 2001; 1: 538-42.

81. Castellani C, Bonizzato A, Mastella G. CFTR mutations and IVS8-5T variant in newborns with hypertrypsinaemia and normal sweat test. J.Med.Genet. 1997; 34: 297-301.

[Seite 46↓]

82. Lowenfels A, Maisonneuve P, Palys B. Re: Ockenga et al.--mutations of cystic fibrosis gene in patients with pancreatitis. Am.J.Gastroenterol. 2001; 96: 614-5.

83. Veeze HJ, Halley DJ, Bijman J, de Jongste JC, de Jonge HR, Sinaasappel M. Determinants of mild clinical symptoms in cystic fibrosis patients. Residual chloride secretion measured in rectal biopsies in relation to the genotype. J.Clin.Invest 1994; 93: 461-6.

84. Bronsveld I, Mekus F, Bijman J et al. Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings. J.Clin.Invest 2001; 108: 1705-15.

85. Noone PG, Zhou Z, Silverman LM, Jowell PS, Knowles MR, Cohn JA. Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology 2001; 121: 1310-9.

86. Audrezet MP, Chen JM, Le Marechal C et al. Determination of the relative contribution of three genes-the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene- to the etiology of idiopathic chronic pancreatitis. Eur.J.Hum.Genet. 2002; 10: 100-6.

87. Lowenfels AB, Maisonneuve P, Cavallini G et al. Prognosis of chronic pancreatitis: an international multicenter study. International Pancreatitis Study Group. Am.J.Gastroenterol. 1994; 89: 1467-71.

88. Lowenfels AB, Maisonneuve P, Whitcomb DC, Lerch MM, DiMagno EP. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA 2001; 286: 169-70.

89. Hartwig W, Werner J, Ryschich E et al. Cigarette smoke enhances ethanol-induced pancreatic injury. Pancreas 2000; 21: 272-8.

90. Silverman DT, Dunn JA, Hoover RN et al. Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J.Natl.Cancer Inst. 1994; 86: 1510-6.

91. Silverman DT, Brown LM, Hoover RN et al. Alcohol and pancreatic cancer in blacks and whites in the United States. Cancer Res. 1995; 55: 4899-905.

92. Silverman DT, Swanson CA, Gridley G et al. Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J.Natl.Cancer Inst. 1998; 90: 1710-9.

93. Falk RT, Pickle LW, Fontham ET et al. Occupation and pancreatic cancer risk in Louisiana. Am.J.Ind.Med. 1990; 18: 565-76.

[Seite 47↓]

94. Patrianakos, C. and Hoffman, D. Chemical studies on tobacco smoke LXIV. On the analysis of aromatic amines in cigarette smoke. J.Anal.Toxicol. 3, 150-159. 1979.

95. Lichtenstein P, Holm NV, Verkasalo PK et al. Environmental and heritable factors in the causation of cancer-- analyses of cohorts of twins from Sweden, Denmark, and Finland. N.Engl.J.Med. 2000; 343: 78-85.

96. Malats, N. Gene-Enviroment Interactions in Pancreatic Cancer. Pancreatology 1, 472-476. 2001.

97. Guengerich. Enzymatic oxidation of xenobiotic chemicals. Crit Rev Biochem Mol Biol 25, 97- 153. 1990.

98. Kadlubar FF, Anderson KE, Haussermann S et al. Comparison of DNA adduct levels associated with oxidative stress in human pancreas. Mutat.Res. 1998; 405: 125-33.

99. Foster, J. R., Idle, J. R., Hardwick, J. P., Bars, R., Scott, P., and Braganza, J. M. Induction of drug-metabolizing enzymes in human pancreatic cancer and chronic pancreatitis. J.Pathol. 169(4), 457-463. 2002.

100. Kessova, I. G., DeCarli, L. M., and Lieber, C. S. Inducibility of cytochromes P-4502E1 and P-4501A1 in the rat pancreas. consequence, coincidence or cause? Alcohol Clin.Exp.Res. 22(2), 501-504. 2002.

101. Acheson DW, Rose P, Houston JB, Braganza JM. Induction of cytochromes P-450 in pancreatic disease: Clin.Chim.Acta 1985; 153: 73-84.

102. Acheson DW, Hunt LP, Rose P, Houston JB, Braganza JM. Factors contributing to the accelerated clearance of theophylline and antipyrine in adults with exocrine pancreatic disease. Clin.Sci.(Lond) 1989; 76: 377-85.

103. Wacke R, Kirchner A, Prall F et al. Up-regulation of cytochrome P450 1A2, 2C9, and 2E1 in chronic pancreatitis. Pancreas 1998; 16: 521-8.

104. Bartsch, H., Malaveille, C., Lowenfels, A. B., Maisonneuve, P., Hautefeuille, A., Boyle, P., and and the International Pancreatic Disease Study Group. Genetic polymorphism of N-actyltransferase, glutathione S transferase M1 and NAD(P)H: quinone oxidoreductase in relation to malignant and benign pancreatic disease risk. Eur.J.Cancer Prev. 7, 215-223. 2002.

105. Tukey RH, Strassburg CP. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu.Rev.Pharmacol.Toxicol. 2000; 40: 581-616.

106. Tukey RH, Strassburg CP. Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract. Mol.Pharmacol. 2001; 59: 405-14.

[Seite 48↓]

107. Strassburg CP, Oldhafer K, Manns MP, Tukey RH. Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue. Mol.Pharmacol. 1997; 52: 212-20.

108. Strassburg CP, Manns MP, Tukey RH. Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8. J.Biol.Chem. 1998; 273: 8719-26.

109. Strassburg CP, Kneip S, Topp J et al. Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine. J.Biol.Chem. 2000; 275: 36164-71.

110. Vogel A, Ockenga J, Ehmer U et al. Polymorphisms of the Carcinogen Detoxifying UDP-Glucuronosyltransferase UGT1A7 in Proximal Digestive Tract Cancer. Z.Gastroenterol. 2002; 40: 497-502.

111. Ockenga, J., Vogel, A., Teich, N., Keim, V., Manns, M., and Strassburg, C. P. Polymorphisms of the UDP-glucuronosyltransferase UGT1A7 are a risk factor of chronic pancreatitis and pancreatic cancer. Gastroenterology (in press).

112. Nowell, S. A., Massengill, J. S., Williams, S., Radominska-Pandya, A., Tephly, T. R., Cheng, Z., Strassburg, C. P., Tukey, R. H., MacLeod, S. L., Lang, N. P., and Kadlubar, F. F. Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazol[4,5- b]pyridine by human microsomal UDPglucuronosyltransferase: identification of specific UGT1A family isoforms involved. Carcinogenesis 20, 1107-1114. 1999.

113. Guillemette C, Ritter JK, Auyeung DJ, Kessler FK, Housman DE. Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene. Pharmacogenetics 2000; 10: 629-44.

114. Strassburg CP, Nguyen N, Manns MP, Tukey RH. Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium. Mol.Pharmacol. 1998; 54: 647-54.

115. Strassburg CP, Vogel A, Kneip S, Tukey RH, Manns MP. Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer. Gut 2002; 50: 851-6.

116. Vogel A, Kneip S, Barut A et al. Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene. Gastroenterology 2001; 121: 1136-44.

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: